Altimmune, Inc. (ALT)

5.27 -0.07 (-1.31%) USD  |  NASDAQ  |  Dec 12, 16:00
5.27 0.00 (0.00%) After-Hours: 20:00
More

Altimmune Total Long Term Debt (Quarterly): 15.66M for Sept. 30, 2025

Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for ALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Debt Definition

View Total Long Term Debt Definition
Start Trial

Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Viking Therapeutics, Inc. 0.318M
Eli Lilly & Co. 42.51B
Pfizer Inc. 61.66B
Terns Pharmaceuticals, Inc. 0.57M
Rhythm Pharmaceuticals, Inc. 259.35M